Prudential Financial’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.46M	Sell	164,500 -21,110	-11%	-$629K	0.01%	890
2025 Q4	$5.53M	Sell	185,610 -9,750	-5%	-$318K	0.01%	864
2025 Q3	$7.06M	Buy	195,360 +6,045	+3%	+$199K	0.01%	762
2025 Q2	$6.81M	Buy	189,315 +9,925	+6%	+$370K	0.01%	771
2025 Q1	$7.07M	Buy	179,390 +10,815	+6%	+$364K	0.01%	711
2024 Q4	$5.07M	Sell	168,575 -136,762	-45%	-$3.92M	0.01%	871
2024 Q3	$7.14M	Buy	305,337 +219,748	+257%	+$4.8M	0.01%	819
2024 Q2	$1.52M	Buy	85,589 +75,035	+711%	+$1.2M	﹤0.01%	1580
2024 Q1	$161K	Sell	10,554 -1	-0%	-$16	﹤0.01%	2491
2023 Q4	$180K	Buy	10,555 +330	+3%	+$3.83K	﹤0.01%	2457
2023 Q3	$85.5K	Sell	10,225 -45,032	-81%	-$628K	﹤0.01%	2455
2023 Q2	$1.37M	Sell	55,257 -88,338	-62%	-$2.28M	﹤0.01%	1642
2023 Q1	$2.16M	Buy	+143,595	New	+$2.18M	﹤0.01%	1288
2022 Q1	–	Sell	-9,391	Closed	-$327K	–	2692
2021 Q4	$327K	Sell	9,391 -1,101	-10%	-$28.6K	﹤0.01%	2368
2021 Q3	$328K	Sell	10,492 -693	-6%	-$21.4K	﹤0.01%	2285
2021 Q2	$434K	Buy	11,185 +310	+3%	+$12.2K	﹤0.01%	2181
2021 Q1	$524K	Buy	10,875 +566	+5%	+$27.2K	﹤0.01%	2115
2020 Q4	$536K	Buy	10,309 +661	+7%	+$22.3K	﹤0.01%	2034
2020 Q3	$259K	Buy	+9,648	New	+$222K	﹤0.01%	2214